Hedge Fund - Baker Bros. Advisors
Biomarin Pharmaceutical Inc (BMRN)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $0 | 0% | 0 | $88.47 |
| 2 | 2023 - Q3 (2023-09-30) | $337,130,743 | 1.94% | 3,810,248 | $88.98 |
| 3 | 2023 - Q2 (2023-06-30) | $330,272,297 | 1.91% | 3,810,248 | $94.11 |
| 4 | 2023 - Q1 (2023-03-31) | $370,508,516 | 2.01% | 3,810,248 | $103.67 |
| 5 | 2022 - Q4 (2022-12-31) | $788,644,924 | 4.73% | 7,620,494 | $93.88 |
| 6 | 2022 - Q3 (2022-09-30) | $645,989,000 | 4.23% | 7,620,494 | $89.04 |
| 7 | 2022 - Q2 (2022-06-30) | $631,510,000 | 3.58% | 7,620,494 | $79.62 |
| 8 | 2022 - Q1 (2022-03-31) | $587,540,000 | 3.37% | 7,620,494 | $83.67 |
| 9 | 2021 - Q4 (2021-12-31) | $673,271,000 | 3.27% | 7,620,494 | $82.51 |
| 10 | 2021 - Q3 (2021-09-30) | $588,988,000 | 2.58% | 7,620,494 | $78.90 |
| 11 | 2021 - Q2 (2021-06-30) | $633,251,000 | 2.78% | 7,589,294 | $79.27 |
| 12 | 2021 - Q1 (2021-03-31) | $573,068,000 | 2.48% | 7,589,294 | $81.69 |
| 13 | 2020 - Q4 (2020-12-31) | $665,505,000 | 2.5% | 7,589,294 | $79.28 |
| 14 | 2020 - Q3 (2020-09-30) | $577,393,000 | 2.3% | 7,589,294 | $101.18 |
| 15 | 2020 - Q2 (2020-06-30) | $936,064,000 | 4.12% | 7,589,294 | $99.39 |
| 16 | 2020 - Q1 (2020-03-31) | $641,295,000 | 3.94% | 7,589,294 | $86.16 |
| 17 | 2019 - Q4 (2019-12-31) | $641,675,000 | 3.41% | 7,589,294 | $75.53 |
| 18 | 2019 - Q3 (2019-09-30) | $511,518,000 | 3.47% | 7,589,294 | $77.02 |
| 19 | 2019 - Q2 (2019-06-30) | $650,023,000 | 4.41% | 7,589,294 | $85.55 |
| 20 | 2019 - Q1 (2019-03-31) | $674,157,000 | 4.31% | 7,589,294 | $92.68 |
| 21 | 2018 - Q4 (2018-12-31) | $646,228,000 | 5.29% | 7,589,294 | $95.13 |
| 22 | 2018 - Q3 (2018-09-30) | $735,332,000 | 4.84% | 7,583,084 | $99.82 |
| 23 | 2018 - Q2 (2018-06-30) | $714,327,000 | 5.36% | 7,583,084 | $87.57 |
| 24 | 2018 - Q1 (2018-03-31) | $614,761,000 | 5.21% | 7,583,084 | $85.82 |
| 25 | 2017 - Q4 (2017-12-31) | $676,184,000 | 5.86% | 7,583,084 | $86.95 |
| 26 | 2017 - Q3 (2017-09-30) | $549,641,000 | 4.45% | 5,905,673 | $88.36 |
| 27 | 2017 - Q2 (2017-06-30) | $536,353,000 | 4.68% | 5,905,673 | $90.98 |
| 28 | 2017 - Q1 (2017-03-31) | $421,913,000 | 3.45% | 4,806,483 | $88.96 |
| 29 | 2016 - Q4 (2016-12-31) | $398,169,000 | 3.9% | 4,806,483 | $86.00 |
| 30 | 2016 - Q3 (2016-09-30) | $444,696,000 | 4.03% | 4,806,483 | $94.17 |
| 31 | 2016 - Q2 (2016-06-30) | $373,944,000 | 3.92% | 4,806,483 | $85.01 |
| 32 | 2016 - Q1 (2016-03-31) | $396,439,000 | 4.18% | 4,806,483 | $81.36 |
| 33 | 2015 - Q4 (2015-12-31) | $431,096,000 | 3.57% | 4,115,083 | $104.32 |
| 34 | 2015 - Q3 (2015-09-30) | $429,321,000 | 3.96% | 4,076,353 | $133.58 |
| 35 | 2015 - Q2 (2015-06-30) | $560,148,000 | 4.91% | 4,095,247 | $123.92 |
| 36 | 2015 - Q1 (2015-03-31) | $523,461,000 | 4.35% | 4,200,456 | $105.95 |
| 37 | 2014 - Q4 (2014-12-31) | $335,741,000 | 3.42% | 3,713,950 | $83.16 |
| 38 | 2014 - Q3 (2014-09-30) | $171,053,000 | 2.15% | 2,370,464 | $65.72 |
| 39 | 2014 - Q2 (2014-06-30) | $118,711,000 | 1.45% | 1,908,230 | $60.41 |
| 40 | 2014 - Q1 (2014-03-31) | $128,455,000 | 1.63% | 1,883,230 | $73.70 |
| 41 | 2013 - Q4 (2013-12-31) | $136,571,000 | 1.92% | 1,941,304 | $67.90 |
| 42 | 2013 - Q3 (2013-09-30) | $56,532,000 | 0.8% | 783,311 | $66.46 |
| 43 | 2013 - Q2 (2013-06-30) | $43,662,000 | 0.86% | 783,311 | $62.32 |
| 44 | 2013 - Q1 (2013-03-31) | $48,769,000 | 0.97% | 783,311 | $56.63 |
| 45 | 2012 - Q4 (2012-12-31) | $9,861,000 | 0.25% | 200,432 | $45.56 |
| 46 | 2012 - Q3 (2012-09-30) | $8,069,000 | 0.17% | 200,432 | $39.29 |
| 47 | 2012 - Q1 (2012-03-31) | $0 | 0% | 0 | $35.67 |
| 48 | 2011 - Q4 (2011-12-31) | $16,766,000 | 0.55% | 487,679 | $32.81 |
| 49 | 2011 - Q3 (2011-09-30) | $10,751,000 | 0.45% | 337,353 | $29.05 |
| 50 | 2011 - Q2 (2011-06-30) | $7,585,000 | 0.29% | 278,758 | $26.32 |
| 51 | 2011 - Q1 (2011-03-31) | $9,758,000 | 0.4% | 388,310 | $25.44 |
| 52 | 2010 - Q4 (2010-12-31) | $13,587,000 | 0.59% | 504,518 | $25.44 |
The displayed share prices are average quarterly stock market prices.